A nurse is preparing to administer 0.9% NaCl 750 mL IV to infuse over 4 hours. The drop factor of the manual IV tubing is 10 gtt/mL. What is the flow rate in gtt/min? (Round to the nearest whole number & fill in the blank with the numerical value only).

A. "The risk of suicidal thoughts is highest during the first few weeks of treatment.": This is the most accurate statement. During the initial weeks of antidepressant therapy, especially in adolescents and young adults, the risk of suicidal ideation may increase as energy levels improve before mood stabilizes. Close monitoring during this period is critical.
B. "Antidepressants eliminate the risk of suicidal thoughts in all patients.": While antidepressants help many patients, they do not eliminate the risk of suicidal thoughts. Some individuals may continue to experience or even develop new suicidal ideation, particularly early in treatment.
C. "Suicidal thoughts are a common side effect experienced by most patients.": Suicidal ideation is a serious but not common side effect. It occurs in a subset of patients, particularly younger individuals, and must be monitored closely, but it is not experienced by the majority.
D. "Suicidal thoughts only occur in patients with a history of suicide attempts.": Suicidal ideation can develop in individuals without a previous history. Risk factors include age, underlying psychiatric conditions, and individual response to medication—not just past behavior.

A. "All antipsychotic drugs carry an equal risk of causing movement-related side effects.": First-generation antipsychotics like Haloperidol are more likely to cause extrapyramidal symptoms due to their potent dopamine D2 receptor blockade. Second-generation antipsychotics carry a lower risk, making this statement inconsistent with clinical evidence.
B. "These side effects happen because this drug blocks dopamine in certain parts of my brain.": Extrapyramidal symptoms are primarily due to dopamine blockade in the nigrostriatal pathway, which regulates motor control. Interference in this region leads to tremors, rigidity, and other movement disorders.
C. "Taking other drugs with my Haloperidol can increase the risk of extrapyramidal symptoms.": Concurrent use of medications that also affect dopamine pathways or have sedative effects can increase the likelihood of developing EPS. Drug interactions are a significant factor in overall risk.
D. "Tardive dyskinesia occurs with prolonged use of an antipsychotic drug.": Long-term use of dopamine-blocking agents, especially at high doses, can lead to tardive dyskinesia. This condition involves involuntary movements and may be irreversible, particularly in older adults.